Nivolumab exposure-response analysis for adjuvant treatment of melanoma supporting a change in posology

Abstract Nivolumab monotherapy is approved as adjuvant treatment for melanoma based on results from the pivotal CheckMate 238 trial. We present a model‐based, benefit-risk assessment of nivolumab in adjuvant melanoma supporting a posology change from a weight‐based to a less frequent, flat‐dosing re...

Full description

Saved in:
Bibliographic Details
Main Authors: Kinjal Sanghavi (Author), Pradeep Vuppala (Author), Vijay Ivaturi (Author), Lora Hamuro (Author), Amit Roy (Author), Satyendra Suryawanshi (Author)
Format: Book
Published: Wiley, 2021-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available